SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is peaq? peaq is a layer-1 blockchain powering the Machine Economy. It is designed to power Decentralized Physical Infrastructure Networks (DePINs) and the billions of devices, robots and vehicles (RWAs) that run on them. At the time of launch, peaq is home to over 50 DePINs in 20+ industries.   What is DePIN?  Decentralized Physical Infrastructure Networks (DePIN) is the name for decentralized applications that use tokens to incentivise communities to build physical infrastructure networks (think mobility, electric vehicle charging, telecoms etc.) from the ground up.  More on DePIN: https://www.peaq.network/blog/what-are-decentralized-physical-infrastructure-networks-depin   Why do DePINs build on peaq? peaq is designed to power real-world Web3 applications. peaq’s Modular DePIN Functions — which include Machine IDs and DePIN Data Verification — work as building blocks DePINs leverage to speed up their development and deployment.   peaq’s DePIN ecosystem enables DePINs to explore synergies with peers, peaq’s DePIN-focused enterprise ecosystem gives DePINs opportunities to expand their demand side, and peaq’s fundamentals give them affordable and fast transactions as well as a high degree of decentralization.  More on peaq’s DePIN-specific features: https://www.peaq.network/blog/peaq-a-layer-1-blockchain-designed-for-depins-decentralized-physical-infrastructure-networks  What can you build on peaq? On peaq, you can build any decentralized application that taps real-world devices to offer services. Some examples of projects built on peaq include:  - Silencio: A DePIN crowdsourcing the world’s largest noise pollution map via a phone app that rewards people with tokens for collecting local noise data, with 360,000+ users across 180 countries. - XMAQUINA: A tokenization platform for autonomous robots behind the world’s first tokenized automatic robo-cafe. - Farmsent: A DePIN for smart agriculture and a peer-to-peer farm produce marketplace which has already onboarded 160,000+ farmers across Asia and South America. - MapMetrics: A drive-to-earn DePIN rewarding people for collecting navigation data via a phone app counting 60,000 users. - Teneo Protocol: A DePIN for crowdsourcing real-time social media data via more than 250,000 Community Nodes.  Explore the peaq ecosystem: https://www.peaq.network/learn/ecosystem   What enterprises does peaq work with? peaq is collaborating with leading IoT manufacturers such as Bosch and is involved in the Bosch-led moveID project, which also includes names like Airbus and Continental. peaq is also collaborating with Mastercard.  Explore the peaq enterprise ecosystem: https://www.peaq.network/learn/ecosystem?category=Enterprises

peaq

PEAQ is garnering considerable attention as it solidifies its role in the decentralized physical infrastructure (DePIN) and machine economy, boosted by a recent Kraken listing and regulatory developments in Dubai. The community is actively discussing its unique approach to integrating AI with tokenized real-world assets, viewing it as an early-stage opportunity with significant long-term growth potential. Many believe its partnerships and expanding ecosystem, including new human wallets joining, underscore its position as a core infrastructure project.

Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD). The company was founded by Carl Spana and John K. A. Prendergast on November 21, 1986 and is headquartered in Princeton, NJ.

Palatin Technologies Inc.

Palatin Technologies is highly active on the feeds after receiving a NYSE American delisting notice, which the company is appealing while concurrently pursuing new financing. This is juxtaposed against recent positive clinical data in dry eye disease and obesity, including a program showing potential for sustained weight maintenance following GLP-1 therapy cessation. The community remains sharply divided, with bulls highlighting the undervalued pipeline and partnership potential, while bears express deep frustration over management's perceived past financial mismanagement and dilution concerns.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

The Cosmos community is engaged in a major discussion surrounding a proposed tokenomics redesign for $ATOM, aiming to transition towards a revenue-based model and address concerns about token dilution. Many holders are expressing frustration over its price performance and historical underperformance, contrasting it with Bitcoin's momentum. Despite this, a segment of the community remains bullish, committed to staking rewards and ATOM's fundamental vision as the "Internet of Blockchains," while also actively debating its role amidst emerging competitive infrastructure plays.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as it recently launched its own prediction markets app, extending its reach into states where traditional sports betting is not yet legal. This strategic move is sparking widespread community discussion regarding its competitive implications and potential for growth. Furthermore, favorable outcomes from recent major sporting events are expected to significantly boost the company's upcoming quarterly results, contributing to ongoing investor debate about its valuation.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Speculation surrounding a potential SpaceX public offering is creating substantial excitement across the aerospace sector, with community discussion intensely focused on identifying indirect investment opportunities. $MNTS is trending due to its touted partnership with SpaceX for upcoming Falcon 9 missions, where it handles critical payload deployments. Its notably low share count is a key talking point, with many drawing comparisons to past volatile 'Meme Stock' plays.

Aave is a decentralized money market protocol where users can lend and borrow cryptocurrency across 20 different assets as collateral. The protocol has a native token called AAVE, which is also a governance token that lets the community decide the direction of the protocol in a collective manner. Lenders can earn interest by providing liquidity to the market, while borrowers can borrow by collateralizing their cryptoassets to take out loans from the liquidity pools.

AAVE

AAVE is trending due to significant recent developments, including the launch of its V4 testnet and a user-friendly iOS savings app aiming for mainstream adoption. The community is buzzing about the proposed $50 million annual token buyback and Aave's strategic focus on Real-World Assets, solidifying its position as a DeFi leader. Many investors view current price levels as an opportune entry, highlighting Aave's superior fundamentals and proactive growth strategies compared to competitors.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is actively discussed amid a flurry of near-term regulatory catalysts, including upcoming FDA decisions for tradipitant, Bysanti, and Hetlioz. The community is particularly energized by positive data for tradipitant's potential in addressing GLP-1 induced nausea, representing a substantial market opportunity, and a recent federal court win challenging FDA action on Hetlioz. This robust pipeline, coupled with insider buying and institutional interest, fuels expectations for significant valuation upside.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe Inc. is a trending topic following its strong quarterly earnings and robust forward guidance, highlighting significant growth from its expanding AI-powered offerings and integrations like ChatGPT. The community is actively debating whether this signals a major rebound for the undervalued software giant, with many anticipating a potential short squeeze due to strong fundamentals, while others remain cautious about intensifying AI competition and the stock's historical performance.

Constellation Brands, Inc. engages in the production, marketing, and distribution of beer, wine, and spirits. It operates through the following segments: Beer, Wine and Spirits, Corporate Operations and Other, and Canopy. The Beer segment includes imported and craft beer brands. The Wine and Spirits segment sells wine brands across all categories-table wine, sparkling wine, and dessert wine-and across all price points. The Corporate Operations and Other segment refers to the costs of executive management, corporate development, corporate finance, human resources, internal audit, investor relations, legal, public relations, and information technology. The Canopy segment consists of canopy equity method Investments. The company was founded by Marvin Sands in 1945 and is headquartered in Rochester, NY.

Constellation Brands Inc - Ordinary Shares - Class A

Constellation Brands Inc

Constellation Brands is actively discussed following recent analyst downgrades and concerns over slowing beer demand, particularly among Hispanic consumers, coupled with inventory rebalancing efforts. While some investors are bearish, citing changing consumption habits and ongoing guidance adjustments, a strong segment of the community views the stock as deeply oversold and a "deal of a decade" due to its robust brand portfolio and speculative market manipulation.

NextEra Energy, Inc. engages in the provision of renewable energy. It operates through the following segments: FPL and NEER. The FPL segment involves the generation, transmission, distribution, and sale of electric energy in Florida. The NEER segment produces electricity from clean and renewable sources, including wind and solar. The company was founded on December 28, 1925 and is headquartered in Juno Beach, FL.

NextEra Energy Inc

NextEra Energy is actively trending as a key beneficiary of the surging electricity demand from AI-driven data centers, evidenced by its significant partnerships with tech giants like Google and Meta for clean energy supply and infrastructure development. The community is keenly discussing NEE's strong positioning as a leader in renewable energy and a stable utility play, especially with the strategic move to restart a nuclear plant to meet future power needs. Investors view its expansive clean energy backlog and diversified portfolio as compelling drivers for long-term growth amidst the broader energy transition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Current Price	$26.08
Prev Close	$25.39
Open	$26.08
Dividend Yield	N/A
50-Day Moving Average	$25.25
Beta	0.58
Avg. Volume	5,470.00
PE Ratio	N/A

52-Week High	$26.29
52-Week Low	$20.08
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

GILD.TSX
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC

Feed

News

Sentiment

Fundamentals

Info

Latest GILD.TSX News

GILD.TSXGilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC